OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Hematology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis	77
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis	50
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia	26
Hormetic endoplasmic reticulum stress in hematopoietic stem cells	26
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies	23
Deficits in our understanding of natural killer cell development in mouse and human	21
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective	20
Developmental regulation of primitive erythropoiesis	18
Mechanisms of immunothrombosis in COVID-19	18
Mesenchymal stromal cells: an update	18
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function	18
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis	18
Disparities in acute myeloid leukemia treatments and outcomes	17
Megakaryocytes as mitochondria factories: potential donors for mitochondria transplantation	17
The impact of obesity-induced inflammation on clonal hematopoiesis	16
Platelet lifespan and mechanisms for clearance	15
Congenital neutropenia: disease models guiding new treatment strategies	15
Unraveling lipid metabolism for acute myeloid leukemia therapy	13
Advances on the genetic basis of red cell membrane disorders	13
Editorial introductions	13
Humanized murine models of platelet function	11
Multifaceted roles of CRISPR technology in blood cancer research	11
High-throughput genotyping tools for red blood cell antigens	10
Editorial introduction	10
Shared host, distinct invaders: metabolomic footprints of plasmodium and babesia in host red cells	10

Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential	10
Hemostatic abnormalities in acute promyelocytic leukemia: clinical implications and mechanisms	9
Targeting hemostatic enzymes: from mechanistic insights to therapeutic frontiers	9
Editorial introductions	8
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation	8
Understanding and targeting erythroid progenitor cells for effective cancer therapy	8
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration	8
Red cells: not only hemoglobin – plasma membranes are also of paramount importance	8
Update on preclinical and clinical efforts on ex-vivo expansion of hematopoietic stem and progenitor cells	7
Red blood cell changes due to cancer and cancer treatments: a narrative review	7
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology	7
Platelets in vascular inflammation: fire-fighters or pyromaniacs?	7
Venous thromboembolism: diagnostic advances and unaddressed challenges in management	7
Editorial introductions	7
The immunology of PF4 polyanion interactions	6
The state of prediction models in hematologic disease: a worrisome assessment	6
Current Opinion in Hematology	6
Modelling arterial thrombus formation in vitro	6
Translation defects in ribosomopathies	6
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods	6
Chediak-Higashi syndrome	6
PROTACs in platelets: emerging antithrombotic strategies and future perspectives	5
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease	5
Models to study myelodysplastic syndrome and acute myeloid leukaemia	5
Editorial introductions	5
Immunomodulatory roles of red blood cells	5
Platelets and platelet–leukocyte interactions in infectious diseases	5
The fulfilled promise and unmet potential of umbilical cord blood	5
Platelet mitochondria: the mighty few	5
Hyperviscosity syndromes; hemorheology for physicians and the use of microfluidic devices	5
Editorial introduction	5
Platelet transfusion	5
The congenital dyserythropoieitic anemias: genetics and pathophysiology	5
No time to die? Intrinsic apoptosis signaling in hematopoietic stem and progenitor cells and therapeutic implications	5
Azacitidine maintenance in AML post induction and posttransplant	4
Switching and increasing prophylaxis regimen with a genetically recombinant fusion of coagulation factor IX and albumin in haemophilia B: a case report	4
Editorial introduction	4
Red cell extracellular vesicles and coagulation activation pathways	4
Hematopoietic stem cell collection for sickle cell disease gene therapy	4
Recent advances in factor XII structure and function	4
Donor selection in allogeneic stem cell transplantation	4
Editorial introduction	4
Germline DDX41 mutations in myeloid neoplasms: the current clinical and molecular understanding	4
Macrocytic anemias	4
Novel approaches to measure transfusion effectiveness	4
Epigenetics of hematopoietic stem cell aging	4
Editorial introduction	4
Proteome remodeling and organelle clearance in mammalian terminal erythropoiesis	4
The impact of prenatal inflammation on hematopoietic development	4
Age-related micro-environmental changes as drivers of clonal hematopoiesis	3

Scoring systems to predict thrombotic complications in solid tumor patients	3
Alteration of interleukin-10-producing Type 1 regulatory cells in autoimmune diseases	3
The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease	3
Advances in chimeric antigen receptor-T therapies to target tumor resistance in B-cell malignancies	3
Crosstalk between terminal erythropoiesis and granulopoiesis within their common niche: the erythromyeloblastic island	3
Role of ATP-dependent chromatin remodelers in hematopoietic stem and progenitor cell maintenance	3
Immunologic effects of red blood cell and platelet transfusions in neonates	3
Direct megakaryopoiesis	3
Iron status of blood donors	3
Platelet Fc gamma RIIA: time to go beyond the unknown	3
Pediatric acute myeloid leukemia – novel approaches	3
The role of stem cell transplantation in the modern management of multiple myeloma	3
N6-methyladenosine in hematological malignancies: a concise review	3
Editorial introductions	3
Chimeric antigen receptor T-cell therapy in acute myeloid leukemia	2
Platelet lipidomics and de novo lipogenesis: impact on health and disease	2
Inflammation and bone marrow fibrosis: novel immunotherapeutic targets	2
microRNAs and thrombo-inflammation: relationship in sight	2
Fibrin structure, viscoelasticity and lysis face the interplay of biorelevant polyions	2
Emerging functional microfluidic assays for the study of thromboinflammation in sickle cell disease	2
The interplay between physical and mental health and its impact on outcomes for hemopoietic stem cell transplant patients	2
Histological differences among thrombi in thrombotic diseases	2
The role of hematopoiesis in bone repair: an update	2
The many faces of the megakaryocytes and their biological implications	2
Regulation of granulocyte colony-stimulating factor-induced hematopoietic stem cell mobilization by the sympathetic nervous system	2
Circulating endothelial cells in pathophysiology	2
Platelet mechanosensing as key to understanding platelet function	2
Editorial introduction	2
New molecules in the therapy of chronic graft-versus-host disease	2
Editorial Introductions	2
Clonal hematopoiesis of indeterminate potential: recent developments and perspectives	2
The new metabolic needs of hematopoietic stem cells	2
Hidden behind thromboinflammation: revealing the roles of von Willebrand factor in sickle cell disease pathophysiology	2
Pas de deux: the coordinated coupling of erythroid differentiation with the cell cycle	2
Editorial introduction	2
PIEZO1, sensing the touch during erythropoiesis	2
Factor XI as a therapeutic target in neuroinflammatory disease	2